心脏病患者使用尼莫地平。 - Suppr

Suppr

超能文献

Nimodipine in patients with heart disease.

作者信息

Roine R O

出版信息

Circulation. 1996 Apr 1;93(7):1472-3; author reply 1473.

PMID:8641041

Abstract

摘要

相似文献

Nimodipine in patients with heart disease.

Circulation. 1996 Apr 1;93(7):1472-3; author reply 1473.

Nifedipine in patients with heart disease.

Circulation. 1996 Apr 1;93(7):1474-5.

Calcium blockers and risk of myocardial infarction and coronary heart disease mortality.

Circulation. 1996 Apr 1;93(7):1472; author reply 1473.

Nifedipine study.

Circulation. 1996 Apr 1;93(7):1472; author reply 1473.

Corrections to the nifedipine meta-analysis.

Circulation. 1996 Apr 1;93(7):1475-6.

Nifedipine trials.

Circulation. 1996 Apr 1;93(7):1473-4.

Antihypertensive therapy, nifedipine, and autonomic dysreflexia.

Arch Phys Med Rehabil. 2002 Sep;83(9):1325-6; author reply 1326.

Risks and benefits of calcium antagonists.

Lancet. 1995 Oct 7;346(8980):962.

Calcium antagonists in coronary artery disease and hypertension. Time for reevaluation?

Circulation. 1995 Sep 1;92(5):1079-82. doi: 10.1161/01.cir.92.5.1079.

Critical appraisal of recent studies on nifedipine and other calcium channel blockers in coronary artery disease and hypertension.

Eur Heart J. 1996 Aug;17(8):1152-7. doi: 10.1093/oxfordjournals.eurheartj.a015031.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Nimodipine in patients with heart disease.

Circulation. 1996 Apr 1;93(7):1472-3; author reply 1473.

Nifedipine in patients with heart disease.

Circulation. 1996 Apr 1;93(7):1474-5.

Calcium blockers and risk of myocardial infarction and coronary heart disease mortality.

Circulation. 1996 Apr 1;93(7):1472; author reply 1473.

Nifedipine study.

Circulation. 1996 Apr 1;93(7):1472; author reply 1473.

Corrections to the nifedipine meta-analysis.

Circulation. 1996 Apr 1;93(7):1475-6.

Nifedipine trials.

Circulation. 1996 Apr 1;93(7):1473-4.

Antihypertensive therapy, nifedipine, and autonomic dysreflexia.

Arch Phys Med Rehabil. 2002 Sep;83(9):1325-6; author reply 1326.

Risks and benefits of calcium antagonists.

Lancet. 1995 Oct 7;346(8980):962.

Calcium antagonists in coronary artery disease and hypertension. Time for reevaluation?

Circulation. 1995 Sep 1;92(5):1079-82. doi: 10.1161/01.cir.92.5.1079.

Critical appraisal of recent studies on nifedipine and other calcium channel blockers in coronary artery disease and hypertension.

Eur Heart J. 1996 Aug;17(8):1152-7. doi: 10.1093/oxfordjournals.eurheartj.a015031.